Clinical Trials
About Clinical Trials Core |
VRC
Home |
WHAT IS A VACCINE?
A vaccine is a substance that stimulates the body's immune
response; the goal of vaccination is to prevent or control
an infection. There are several different types of vaccines.
The types of vaccines that are being studied to prevent HIV/AIDS
are subunit vaccines, recombinant vector vaccines, and DNA
vaccines. These vaccines contain only some of the many substances
that HIV needs to make more copies of itself; the vaccines
themselves cannot cause HIV or AIDS.
A given HIV vaccine may be used either alone
or in combination with another HIV vaccine. One approach to
HIV vaccination is called the prime-boost strategy, which
combines two different types of HIV vaccines.
Subunit Vaccines
Subunit vaccines, also known as "component"
vaccines, contain only individual proteins or peptides from
HIV, rather than the whole virus. Instead of collecting protein
or peptide components from the virus itself, they are made
in the laboratory using genetic engineering techniques. Most
HIV subunit vaccines are based on laboratory-made forms of
the HIV envelope proteins that coat the outside of the virus.
These envelope proteins can prompt the body to produce an
anti-HIV immune response.
Another type of subunit vaccine is called a
virus-like particle vaccine (also known as a VLP or pseudovirion
vaccine). Virus-like particles are non-infectious HIV look-alikes
that contain one or more, but not all, HIV proteins.
Recombinant Vector Vaccines
Recombinant vector vaccines are based on
microorganisms such as viruses or bacteria that do not cause
disease in humans or have been weakened so as not to cause
disease. The viruses or bacteria are used as vectors, or carriers,
to deliver harmless HIV genes into the cells of the body.
The body produces proteins from the HIV genes and these proteins
stimulate an anti- HIV immune response.
Some of the viral vectors being studied for
HIV vaccines include ALVAC (a canarypox virus), MVA (a cowpox
variant), and ADV5 (adenovirus 5). A modified version of the
bacterium Salmonella typhi is also being studied as a vector
for HIV vaccines. Most of the recombinant vector vaccines
for HIV deliver several HIV genes.
DNA Vaccines
DNA vaccines introduce pieces of laboratory-made
HIV DNA into the body. Unlike recombinant vector vaccines,
DNA vaccines do not rely on a viral or bacterial vector. Instead,
"naked" DNA containing HIV genes is injected directly
into the body. Cells take up this DNA and use it to produce
HIV proteins. The proteins trigger the body to produce an
anti-HIV immune response.
Prime Boost Strategies
A prime-boost strategy is one approach
to HIV vaccination. In this approach, administration of one
type of HIV vaccine (such as a recombinant vector vaccine)
is followed by a second type of HIV vaccine (such as a subunit
vaccine). The goal of this approach is to stimulate different
kinds of immune responses and enhance the body's overall immune
response to HIV.
|